Related Experiment Video

Updated: Jul 2, 2026

Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound (30/45MHZ) System
07:34

Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound (30/45MHZ) System

Published on: May 5, 2018

Cardiovascular disease and heritability of the prothrombotic state

R A Ajjan1, R A S Ariëns

  • 1Division of Diabetes and Cardiovascular Research, Leeds Institute for Genetics, Health and Therapeutics, LIGHT Laboratories, University of Leeds, Leeds, United Kingdom.

Blood Reviews
|August 30, 2008
PubMed

Insights

Genetic factors significantly influence atherothrombotic disease risk. This review explores genetic variations in clotting factors and gene-environment interactions to improve prevention and treatment strategies for this common condition.

Area of Science:

  • Cardiovascular Genetics
  • Thrombosis Research
  • Molecular Medicine

Background:

  • Atherothrombotic disease is a leading cause of global mortality.
  • Family studies indicate a substantial genetic contribution to disease development.
  • Thrombus formation, the final stage of atherothrombosis, is influenced by genetic and environmental factors.

Purpose of the Study:

  • To review the genetic factors regulating thrombosis potential.
  • To examine the impact of genetic variations on atherothrombotic disease development.
  • To highlight gene-gene and gene-environment interactions in thrombosis.

Main Methods:

  • Review of existing literature on genetic polymorphisms in clotting factors.
  • Analysis of studies investigating gene-gene interactions in thrombotic conditions.
  • Examination of gene-environment interactions influencing atherothrombosis.

Main Results:

  • Common genetic polymorphisms in clotting factors affect thrombosis potential.
  • Complex gene-gene interactions play a role in atherothrombotic disease predisposition.
  • Gene-environment interactions significantly modify the risk of thrombotic events.

Conclusions:

  • Understanding genetic predispositions is crucial for deciphering atherothrombotic disease pathophysiology.
  • Elucidating complex genetic and environmental interactions can lead to novel preventative strategies.
  • Genetic insights are vital for developing targeted treatments for atherothrombotic conditions.

More Related Videos

Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States07:09

Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States

Published on: April 1, 2015

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Heritability01:06

Heritability

Heritability is a statistical concept that measures the degree to which genetic differences among individuals contribute to trait variations within a population. It is a fundamental idea in genetics, often prone to misinterpretation. Heritability is expressed as a percentage, reflecting the proportion of variation in a specific trait across a population that can be linked to genetic differences. However, it's important to understand that heritability does not determine how "genetic" a trait is,...